Deidra Merriwether
About Deidra Merriwether
Deidra (Dee) Merriwether has served as Senior Vice President and Chief Financial Officer (CFO) of W.W. Grainger, Inc. since January 12, 2021 (age 51 at appointment) after leading North American Sales & Services and prior executive roles in finance, pricing, and U.S. direct sales . Grainger delivered $17.2B in 2024 sales (+4.7% daily, organic constant currency), adjusted ROIC of 41.6%, and one-year/three-year TSR of 28.2%/109.8%, anchoring pay-for-performance across annual incentives and PSUs . The 2024 MIP payout was 97% of target (sales growth 4.5% → 45% payout; adjusted ROIC 41.4% → 53% payout; ESG modifier 0%) .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| W.W. Grainger | CFO (SVP) | Jan 2021–present | Oversees finance; supports strategy execution and profitable growth . |
| W.W. Grainger | SVP & President, North American Sales & Services | 2020–2021 | Led sales, solutions, customer engagement across North America . |
| W.W. Grainger | SVP, U.S. Direct Sales & Strategic Initiatives | 2017–2020 | Led new pricing strategy; strengthened large/medium customer relationships . |
| W.W. Grainger | VP, Pricing & Indirect Procurement | 2016–2017 | Led pricing and procurement capabilities . |
| W.W. Grainger | VP Finance, Americas | 2013–2016 | Head of North America Finance . |
| Sears Holdings; PricewaterhouseCoopers; Eli Lilly | Finance/other roles | Not disclosed | Delivered consistent top quartile performance (prior to Grainger) . |
External Roles
| Organization | Role | Years |
|---|---|---|
| Weyerhaeuser Company | Director | Since Nov 2020 (at time of 8-K) . |
| Ann & Robert H. Lurie Children’s Hospital of Chicago | Board/Nonprofit leadership | Not disclosed . |
Fixed Compensation
Multi-year compensation (Summary Compensation Table – amounts as reported):
| Metric | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|
| Salary ($) | 668,750 | 693,836 | 718,784 |
| Stock Awards – Grant-Date Fair Value ($) | 1,726,159 | 2,000,793 | 2,224,167 |
| Non-Equity Incentive Plan Comp. ($) | 1,075,275 | 873,905 | 703,250 |
| All Other Comp. ($) | 89,944 | 110,883 | 100,775 |
| Total ($) | 3,560,128 | 3,679,417 | 3,746,976 |
Additional fixed pay specifics:
- Annualized base salary increased to $725,000 effective March 31, 2024 (+3.6% YoY) .
- 2024 target annual incentive: 100% of base salary; actual payout: 97% of target .
- Perquisites include executive physical ($5,245) and retirement savings/SPSP contributions ($95,530) in 2024 .
Performance Compensation
2024 Annual Incentive (MIP) design and outcomes:
| Metric | Weighting | Target (100% payout scale) | Actual 2024 | Payout % | Vesting |
|---|---|---|---|---|---|
| Total Company Daily, Organic Constant Currency Sales Growth | Not disclosed | 11.3% → 100% payout | 4.5% | 45% | Annual cash (no vesting) |
| Total Company Adjusted ROIC | Not disclosed | 44.0% → 100% payout | 41.4% | 53% | Annual cash (no vesting) |
| ESG Modifier (Scope 1&2; diverse leadership) | ±10 ppt | N/A | 0% | 0% | N/A |
| Final MIP Payout | — | — | — | 97% of target | Annual cash |
2022–2024 PSU cycle (final results approved at 118% of target):
- Metrics (equally weighted): U.S. share gain (+465 bps over period), Endless Assortment daily sales growth (+14.2%), total Company adjusted operating margin expansion (+119 bps); three-year performance period and cliff vest .
- Merriwether’s 2024 LTIP target value: $2,200,000 (50% PSUs, 50% RSUs; PSUs three-year cliff; RSUs three-year graded) .
2024 LTIP grants:
| Award Type | Grant Date | Shares Granted | Fair Value ($) | Vesting |
|---|---|---|---|---|
| PSUs | 4/1/2024 | 1,105 target; 0–200% earnout | 1,100,050 | 3-year cliff (2024–2026) |
| RSUs | 4/1/2024 | 1,105 | 1,124,117 | 3-year graded (2024–2026) |
Option exercises and stock vesting realized in 2024:
| Item | Quantity | Value ($) |
|---|---|---|
| Options exercised | 8,301 shares | 5,819,048 |
| Shares vested (RSUs/PSUs) | 4,807 shares | 5,006,453 |
Equity Ownership & Alignment
Beneficial ownership and guideline compliance:
| Holding Detail (as of Feb 28, 2025) | Amount |
|---|---|
| Shares owned | 6,852 |
| Stock options exercisable within 60 days | 2,339 (exercise price $311.26; expires 3/31/2029) |
| Stock units (RSUs credited) | 2,657 |
| Percent of class | <1% |
| Stock ownership guideline | 3x base salary; in compliance |
| Hedging/Pledging | Prohibited; none by executives |
Outstanding unvested awards and vesting schedule:
| Vest Date | RSUs (count) | PSUs (count) |
|---|---|---|
| Apr 1, 2025 | 569; 491; 368 | 2,012 (final 2022 PSU payout) |
| Apr 1, 2026 | 492; 368 | 2,948 (assumed at max for disclosure) |
| Apr 1, 2027 | 369 | 2,210 (assumed at max for disclosure) |
Outstanding equity value (year-end 2024 close $1,054.05):
- Unvested RSUs: 4,669 units; market value $4,921,359 .
- Unearned PSUs outstanding (max): 5,158 units; payout value $5,436,790 .
Employment Terms
- Employment agreements: The company does not maintain employment agreements with NEOs .
- Change-in-control: Double-trigger CIC agreements; lump-sum cash equal to 2x (salary + target annual incentive + average supplemental profit sharing %) plus two years of health/dental benefits .
- Event-specific economics for Merriwether (as of 12/31/2024):
| Scenario | Cash Payments ($) | RSU Acceleration ($) | PSU Acceleration ($) | Benefits/Other ($) | Total ($) |
|---|---|---|---|---|---|
| Involuntary Termination (without cause) | 1,450,000 | 1,506,062 | 3,900,776 | 172,711 (benefits + 401k + outplacement) | 7,029,549 |
| Change in Control + Termination (double trigger) | 3,074,000 | 2,800,611 | 4,515,550 | 149,766 (benefits + outplacement) | 10,539,927 |
| Death or Disability | — | 2,800,611 | 4,515,550 (settled at target) | — | 7,316,161 |
Other terms:
- Retirement plan eligibility: Not eligible for frozen EDBP; continued 401(k) contribution eligibility for 12 months upon involuntary termination .
- Clawbacks: Equity Award Agreement Clawback Provisions and NYSE-compliant clawback policy in place .
- Deferred compensation (SPSP): 2024 registrant contribution $86,313; aggregate balance $640,476 .
Investment Implications
- Pay-for-performance alignment: Annual incentives tied to sales growth and ROIC with transparent scales; long-term PSUs equally weighted across share gain, Endless Assortment growth, and adjusted operating margin, producing a 118% payout for the 2022–2024 cycle as performance exceeded targets .
- Insider selling pressure: Significant realized liquidity in 2024 from option exercises ($5.82M) and vestings ($5.01M). Upcoming vesting events on Apr 1, 2025–2027 (RSUs and PSUs) could add supply; monitor Form 4 filings around these dates .
- Alignment and risk controls: 3x salary ownership guideline (in compliance) and prohibition on hedging/pledging reduce misalignment and leverage risk; strong clawback regime further mitigates downside governance risk .
- Retention economics: CIC double-trigger and 2x cash multiple plus equity acceleration provide retention through strategic cycles, while standard severance (12 months pay/benefits) offers transition protection without single-trigger concerns .
Best AI for Equity Research
Performance on expert-authored financial analysis tasks
Best AI for Equity Research
Performance on expert-authored financial analysis tasks